39 results
8-K
PTPI
Petros Pharmaceuticals Inc
25 Feb 21
Departure of Directors or Certain Officers
4:15pm
, at an initial base salary of $350,000 per annum. Mr. Boctor will receive a signing bonus in the amount of $250,000 (the “Signing Bonus”), payable … that in the event that Mr. Boctor does not remain employed by Petros on May 1, 2022, he shall be obligated to repay to Petros the Signing Bonus, unless
8-K
EX-10.1
PTPI
Petros Pharmaceuticals Inc
15 Dec 20
Departure of Directors or Certain Officers
5:14pm
Exhibit 10.1
BONUS AGREEMENT
This Bonus Agreement (this “Agreement”) is made and entered into as of December 11, 2020, by and between Petros … Pharmaceuticals, Inc. (“Petros”) and Fady Boctor (“Employee”).
WHEREAS, the Company has determined that it is appropriate to award a bonus to Employee
8-K
PTPI
Petros Pharmaceuticals Inc
15 Dec 20
Departure of Directors or Certain Officers
5:14pm
. (“Petros”), Petros and Mr. Boctor entered into a Bonus Agreement (the “Bonus Agreement”), pursuant to which Petros agreed to award Mr. Boctor a bonus … in the amount of $125,000 payable on December 15, 2020. The Bonus Agreement provides that in the event that Mr. Boctor is not employed by Petros on June
8-K
EX-10.1
PTPI
Petros Pharmaceuticals Inc
25 Feb 21
Departure of Directors or Certain Officers
4:15pm
of Directors and nothing herein shall be deemed to require any such increase.
B. Signing Bonuses. You shall receive a signing bonus in the amount … 3.B.
C. Annual Bonuses. Commencing calendar year 2021, you shall be eligible to earn an annual performance-based cash bonus (the “Annual Bonus
PRE 14A
n40cha imnha5
30 Sep 22
Preliminary proxy
4:45pm
DEF 14A
dgnjoupdh1ehp
22 Nov 21
Definitive proxy
4:37pm
10-K
rh12q
31 Mar 21
Annual report
4:30pm
8-K/A
EX-10.1
yjsftq24f 6y
31 Dec 20
Metuchen’s Management’s Discussion and Analysis of Financial Condition and Results of Operations
5:00pm
8-K/A
zvn5x15m4 alrrnx
31 Dec 20
Metuchen’s Management’s Discussion and Analysis of Financial Condition and Results of Operations
5:00pm
424B3
v3svz
14 Jan 22
Prospectus supplement
5:18pm
8-K
EX-10.1
bptjnzbamxqw16
4 Mar 22
Departure of Directors or Certain Officers
5:00pm